Prospective study on the safety of risk-reducing surgery for gynecological cancer of Hereditary breast ovarian cancer syndrome (HBOC) patient

Prospective study on the safety of risk-reducing surgery for gynecological cancer of Hereditary breast ovarian cancer syndrome (HBOC) patient - RRSO study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024243

Enrollment

Registered

2016-10-01

Start date

2016-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast ovarian cancer syndrome

Interventions

Risk reducing surgery

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Having a deleterious mutation of BRCA1/2 germline gene

Exclusion criteria

Exclusion criteria: BRCA

Design outcomes

Primary

Measure	Time frame
Adverse event	—

Countries

Japan

Contacts

Public ContactRyutaro Nishikawa

Nagoya city university Obstetrics and gynecology

ryu0717@med.nagoya-cu.ac.jp052-853-8241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026